PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Mylan
MY

Mylan

Potters Bar
Large

Viatris is a global healthcare company that empowers people worldwide to live healthier at every stage of life. They provide high quality, trusted medicines and have a broad portfolio of products across various therapeutic areas.

mylan.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£240.6m
Live
53
Buyers
8
12m
—
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities6
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts53 / 77
  • Top buyers8
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — MylanUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Mylan has won £240.6m across 8 public-sector buyers, with 53 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 91% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
53 of 77Live contracts
91%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 3
Access to MedicinesProviding high quality, trusted medicines, regardless of geography or circumstance.
Sustainable OperationsAdvancing sustainable operations and innovative solutions to improve patient health.
PartnershipsLeveraging collective expertise to connect people to products and services.
Frameworks & DPS · 6 from notices
  • NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England · £13.3m
  • NHS Framework for the North of England, Branded MedicineNHS England · £7.7m
  • NHS Framework Agreement for Branded medicines - NationalNHS England · £6.1m
  • NHS Framework Agreement - North of England - Tranche BNHS England · £5.6m
  • Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (T&T) · £1.7m
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k

Extracted automatically from mylan.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 53 live · 24 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National
NHS England3360000001 Sept 2025£9.4m2 yrsLive
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
NHS England3360000001 Jun 2025£376k2 yrsLive
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024
NHS England3360000001 Nov 2024£48.2m2 yrsLive
NHS National Framework for Transition products commencing 1 May 2024
NHS England3360000001 May 2024£630k17 moClosed
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
NHS England3360000001 Mar 2024£17.6m2.5 yrsLive
NHS London Branded Medicines - Tranche B - September 2023
NHS England3360000001 Sept 2023£6.4m2 yrsClosed
CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins
NHS England3360000001 Sept 2023£23.3m2 yrsClosed
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
NHS England3360000001 May 2023£6.1m2 yrsClosed
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche
NHS England3360000001 Mar 2023£13.7m2 yrsClosed
Total live value £75.6m · mean award £3.1m1–10 of 77

Top buyers · 8 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
48 contracts
91%
since 2018
2
NHSE&I
1 contract
6%
since 2022
3
Department of Health and Social Care (T&T)
4 contracts
2%
since 2020
4
NHS England and NHS Improvement
1 contract
0%
since 2022
5
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
12 contracts
0%
6
The NHS Commissioning Board (operating under the name of NHS England)
7 contracts
0%
7
Procurement and Logistics Service
1 contract
0%
8
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
3 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire49 contracts
100%
Scotland12 contracts
0%
North West7 contracts
0%
Northern Ireland1 contract
0%
Wales3 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Mylan highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
AS
AstraZeneca
No£247.9m7
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
MY
Mylan
No——
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 07 Sept 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
09189103
Status
Active
Type
Private limited
Incorporated
28 Aug 2014
Reg. office
20 Station Close, Potters Bar, EN6 1TL
SIC codes
46460
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • BALCHIN, James Anthony — director
    Appointed 31 Oct 2025
  • FISHER, Melissa — director
    Appointed 08 Mar 2024
  • NARAYAN, Arun — director
    Appointed 17 Jul 2023
  • Viatris Inc. — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · voting rights 75 to 100 percent as firm · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
VIATRIS UK HEALTHCARE LIMITED
09189103 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.